top of page
Breast Implant Illness
AFC72092-874B-4CF0-AEFF-2D91A0F5CF33_1_105_c.jpeg
Stomach Ache
F4EFE1C4-F137-401B-954F-9BA4A750F38E_1_105_c.jpeg
Proper informed consent
is crucial. We developed a
Patient Decision Checklist.
9AD5B3F5-BA29-483C-AC4E-FE267C0F7BCD_1_105_c.jpeg
Doctor Checking a Form

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

Breast Implant Illness Groups
AZ Patient Decision Checklist

GPAC Resources

TRADUIT en FRANÇAIS

(French Translation)

 

BREAST IMPLANT STUDIES

MD Anderson | 2018 Largest Ever Study Shows Silicone Breast Implants Associated with Rare Diseases

MD Anderson | 2018

Dr. Brian Buinewicz, Danielle Valoras, and Robyn Towt | May 2023
Understanding Breast Implant Illness

Dr. Buinewicz, Valoras & Towt | 2023

Dr. Lu-Jean Feng Study | July 2020
Understanding Breast Implant Illness, Before and After Explantation A Patient-Reported Outcomes 

Dr. Feng Study | 2020

Dr. Magno-Padron et al Study | July 2021
A Population Study of Breast Implant Illness 

Dr. Magno-Padron Study | 2021

Dr. Rita Kappel Study | April 2016
Gel Bleed and Rupture of Silicone Breast Implants Investigated by Light-,Electron Microscopy and Energy Dispersive X-ray Analysis of Internal Organs and Nervous Tissue

Dr. Kappel Study | 2016

Dr. Eduardo Fleury | Jan. 2021
The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma

Dr. Fleury Study | 2021

Dr. Arthur Brawer | 2019
The Clever Deception by Silicone Gel-filled Breast Implant Manufacturers Regarding the Phenomenon of GelBleed

Dr. Brawer Study | 2019

Dr. Brian Buinewicz | Sept. 2021
Outcomes of Implant Removal and Capsulectomy for Breast Implant Illness in 248 Patients

Dr. Buinewicz Study | 2021

Dr. Lu-Jean Feng | Sept. 1999
Analysis of Risk Factors Associated with Rupture of Silicone Gel Breast Implants
 

Dr. Feng Study | 1999

Dr. Lu-Jean Feng | April 2005
Pathology of Lymph Nodes From Patients with Breast Implants

Dr. Feng Study | 2005

Dr. Tervaert et al | Jan. 2022
Breast Implant Illness: Scientific Evidence of its existence

Dr. Tervaert Study | 2022

Dr. Tervaert et al | July 2016
Two Hundred Cases of ASIA Syndrome Following Silicone Implants

Dr. Tervaert Study | 2016
036CE7B7-3C5D-49F3-9D10-866C521EE131.jpeg

FDA BREAST IMPLANT SAFETY ANNOUNCEMENTS

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

FDA September 2020 | Breast Implants - Certain Labeling Recommendations to Improve Patient Communication
FDA Black Box Warning

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

FDA September 2022 | FDA Breast Implant Cancers
FDA Breast Implant Cancers

FDA September 2020 | Medical Device Reports for Systemic Symptoms in Women with Breast Implants

FDA September 2020 - Medical Device Reports for Systemic Symptoms in Women with Breast Implants 
FDA Systemic Symptoms

FDA September 2020 | 7 Things You Should Know About Breast Implants

FDA September 2020 - 7 Things You Should Know About Breast Implants
7 Things You Should Know

FDA August 2020 | FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant Associated Lymphoma 

FDA August 2020 - FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant Associated Lymphoma
FDA Update | August 2020

FDA August 2020 | FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant Associated Lymphoma 

FDA September 8, 2022 | Reports of Squamous Cell Carcinoma and Various Lymphomas in Capsule Around Implants
FDA Breast Implant Cancers

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

FDA Breast Implant SSED - Summary of Safety and Effectiveness Data
FDA Breast Implant Labeling

 

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

FDA Food and Drug Administration (United States)
FDA (United States)

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

Health Canada (Canada) 
Health Canada

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

MHRA Medicines and Heathcare products Regulatory Agency (United Kingdom)
MHRA (United Kingdom)

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

TGA Therapeutic Goods Administration (Australia)
TGA (Australia)

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

BfArM Federal Institute for Drugs and Medical Devices (Germany)
BfArM (Germany)
bottom of page